• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短效磺胺类药物及N4-乙酰磺胺衍生物在人体中的药代动力学及肾脏排泄机制。磺胺类药物主动肾小管分泌的结构要求。

Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.

作者信息

Vree T B, Hekster Y A, Damsma J E, Tijhuis M, Friesen W T

出版信息

Eur J Clin Pharmacol. 1981;20(4):283-92. doi: 10.1007/BF00618779.

DOI:10.1007/BF00618779
PMID:7308281
Abstract

The pharmacokinetics of short acting sulphonamides and a series of N4-acetylsulphonamide derivatives has been investigated. Sulphonamides with a sulphur atom two atomic bond distances from the N1 atom are excreted by active tubular secretion, e.g. sulphamethizole, sulphaethidole and sulphathiasole. When the sulphur atom is replaced by an oxygen or nitrogen atom, active renal excretion no longer occurs. N4-acetylsulphonamides are excreted by active tubular secretion. The renal clearance values of the N4-acetylsulphonamides are not influenced by the substituent at the N1 position. Two groups of N4-acetylsulphonamides can be distinguished. One has a T1/2 of 4-6 h and a renal clearance value of 20-60 ml/min and the second has a T1/2 of 10-20 h and a renal clearance of less than 10 ml/min. N4-acetylsulphonamides are deacetylated to the extent of about 5%.

摘要

已对短效磺胺类药物及一系列N4 - 乙酰磺胺衍生物的药代动力学进行了研究。与N1原子相距两个原子键距离处带有硫原子的磺胺类药物通过肾小管主动分泌排出,例如磺胺甲噻二唑、磺胺乙噻唑和磺胺噻唑。当硫原子被氧原子或氮原子取代时,肾脏主动排泄不再发生。N4 - 乙酰磺胺类药物通过肾小管主动分泌排出。N4 - 乙酰磺胺类药物的肾脏清除率不受N1位取代基的影响。可区分出两组N4 - 乙酰磺胺类药物。一组的半衰期为4 - 6小时,肾脏清除率为20 - 60毫升/分钟,另一组的半衰期为10 - 20小时,肾脏清除率小于10毫升/分钟。N4 - 乙酰磺胺类药物的脱乙酰化程度约为5%。

相似文献

1
Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.短效磺胺类药物及N4-乙酰磺胺衍生物在人体中的药代动力学及肾脏排泄机制。磺胺类药物主动肾小管分泌的结构要求。
Eur J Clin Pharmacol. 1981;20(4):283-92. doi: 10.1007/BF00618779.
2
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.人体中某些磺胺类药物乙酰化表型及药代动力学的测定
Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.
3
Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.N1-乙酰基和N4-乙酰基磺胺甲恶唑在人体中的药代动力学
Clin Pharmacokinet. 1979 Jul-Aug;4(4):310-9. doi: 10.2165/00003088-197904040-00004.
4
Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.磺胺类药物N-取代基中甲氧基对人体消除途径的影响。磺胺异嘧啶、磺胺甲嘧啶和磺胺二甲氧嘧啶的乙酰化-去乙酰化平衡及肾脏排泄机制。
Pharm Weekbl Sci. 1984 Aug 24;6(4):150-6. doi: 10.1007/BF01954042.
5
The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.磺酰胺类密切相关的N1-取代基的分子结构对人体消除途径的影响。与磺胺嘧啶、磺胺甲嘧啶和磺胺二甲嘧啶结构相关的乙酰化-去乙酰化平衡及肾清除率。
Pharm Weekbl Sci. 1983 Apr 29;5(2):49-56. doi: 10.1007/BF01960075.
6
Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfamethomidine in humans.磺胺脒在人体内的药代动力学、N1-葡萄糖醛酸化和N4-乙酰化
Pharm Weekbl Sci. 1991 Oct 18;13(5):198-206. doi: 10.1007/BF01988875.
7
Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives.磺胺类药物及其N4-乙酰衍生物的临床药代动力学。
Antibiot Chemother (1971). 1982;31:22-118. doi: 10.1159/000400131.
8
Renal tubular excretion of the N4-acetyl metabolites of sulphasomidine and sulphadimethoxine in the dog.
J Pharm Pharmacol. 1993 Jul;45(7):614-7. doi: 10.1111/j.2042-7158.1993.tb05663.x.
9
Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylators.
Biopharm Drug Dispos. 1983 Jul-Sep;4(3):271-91. doi: 10.1002/bdd.2510040308.
10
Pharmacokinetics, metabolism and renal excretion of sulfatroxazole and its 5-hydroxy- and N4-acetyl-metabolites in man.磺胺异恶唑及其5-羟基和N4-乙酰代谢物在人体中的药代动力学、代谢和肾排泄
Biopharm Drug Dispos. 1986 May-Jun;7(3):239-52. doi: 10.1002/bdd.2510070305.

引用本文的文献

1
Pharmacokinetic considerations in rational drug design.合理药物设计中的药代动力学考量
Clin Pharmacokinet. 1994 Mar;26(3):161-8. doi: 10.2165/00003088-199426030-00001.
2
The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.磺酰胺类密切相关的N1-取代基的分子结构对人体消除途径的影响。与磺胺嘧啶、磺胺甲嘧啶和磺胺二甲嘧啶结构相关的乙酰化-去乙酰化平衡及肾清除率。
Pharm Weekbl Sci. 1983 Apr 29;5(2):49-56. doi: 10.1007/BF01960075.
3

本文引用的文献

1
Renal tubular secretion of sulfonamides and p-aminobenzoic acid.磺胺类药物和对氨基苯甲酸的肾小管分泌
Acta Pharmacol Toxicol (Copenh). 1945;1(3):307-24. doi: 10.1111/j.1600-0773.1945.tb02584.x.
2
Acetylation and deacetylation of the p-amino group of sulphonamide drugs in animal tissues.动物组织中磺胺类药物对氨基的乙酰化和去乙酰化作用。
Biochem J. 1947;41(4):622-30. doi: 10.1042/bj0410622.
3
Factors basic to the development of useful inhibitors of renal transport mechanisms.肾转运机制有效抑制剂开发的基础因素。
Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs.
4-羟基磺胺甲基嘧啶的分离鉴定及其在犬体内的药代动力学初步研究
Pharm Weekbl Sci. 1984 Apr 27;6(2):80-7. doi: 10.1007/BF01953959.
4
Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.磺胺类药物N-取代基中甲氧基对人体消除途径的影响。磺胺异嘧啶、磺胺甲嘧啶和磺胺二甲氧嘧啶的乙酰化-去乙酰化平衡及肾脏排泄机制。
Pharm Weekbl Sci. 1984 Aug 24;6(4):150-6. doi: 10.1007/BF01954042.
5
Effect of intra-articular glucocorticoids on the disposition of sulphadimidine in chronic osteoarthritis patients.关节内注射糖皮质激素对慢性骨关节炎患者磺胺二甲嘧啶处置的影响。
Br J Clin Pharmacol. 1988 Nov;26(5):563-8. doi: 10.1111/j.1365-2125.1988.tb05296.x.
Arch Int Pharmacodyn Ther. 1954 May 1;98(1):97-117.
4
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.人体中某些磺胺类药物乙酰化表型及药代动力学的测定
Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.
5
Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.肾功能受损患者中磺胺甲恶唑及其代谢产物N4-乙酰磺胺甲恶唑的肾脏排泄情况。
Ther Drug Monit. 1981;3(2):129-35. doi: 10.1097/00007691-198102000-00003.
6
A definition of substrate specificity in renal transport of organic anions.有机阴离子肾转运中底物特异性的定义。
J Theor Biol. 1965 Jan;8(1):163-92. doi: 10.1016/0022-5193(65)90101-3.
7
Progress in sulfonamide research.
Prog Drug Res. 1968;12:389-457. doi: 10.1007/978-3-0348-7065-8_7.
8
Sulfonamides, structure-activity relationship, and mode of action. Structural problems of the antibacterial action of 4-aminobenzoic acid (PABA) antagonists.
J Pharm Sci. 1968 Sep;57(9):1455-78. doi: 10.1002/jps.2600570902.
9
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.多种N-乙酰基转移酶与药物代谢。哺乳动物N-乙酰基转移酶的组织分布、特性及意义。
Biochem J. 1973 Mar;132(3):519-26. doi: 10.1042/bj1320519.
10
Metabolism of procainamide in rhesus monkey and man.普鲁卡因酰胺在恒河猴和人类中的代谢。
Clin Pharmacol Ther. 1972 May-Jun;13(3):366-71. doi: 10.1002/cpt1972133366.